CIK: 1586745 - Address: 128 Sidney Street, Cambridge, MA 02139
35 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret11211-1135-11
S%wins48526262456155

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/14/16 17:49
11/9/16
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.d5465.461110088214D159202993742382-6-27-35
11/14/16 17:49
11/9/16
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS.d-3,21932.1911-100-32214D159202993742382-6-27-35
7/7/16 16:03
7/7/16
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.d1711.80139580214D1016-1480-6312-3-24-19
7/6/16 17:44
7/1/16
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.dm5025.281395394119D-28-2710-4-8-6-6-22-13-27
7/6/16 17:44
7/1/16
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS.dm-3,38733.8713-100-46119D-28-2710-4-8-6-6-22-13-27
5/20/16 16:41
5/18/16
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.dm4455.081188239124D40-82151042124-1117
5/20/16 16:41
5/18/16
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS.dm-3,30733.0711-100-45124D40-82151042124-1117
10/9/15 17:04
10/7/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.d975.08101919119D5-20-29-19-15-320-1-2164432639
10/9/15 17:04
10/7/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS.d-46324.3810-19-14119D5-20-29-19-15-320-1-2164432639
9/15/15 18:10
9/14/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.d30.4000698119D32-171018261610-7-4-3820-28-6
9/10/15 16:54
9/8/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.d975.0861973522D26-24-110151141-2531-200
9/10/15 16:54
9/8/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS.d-57430.206-19-4722D26-24-110151141-2531-200
8/12/15 17:55
8/10/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.d975.0841973522D-5-25-11-10-12-131371235-110
8/12/15 17:55
8/10/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS.d-54228.534-19-4722D-5-25-11-10-12-131371235-110
8/3/15 20:19
7/30/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.d20.4000442322D-3-270-8-5-11-10-306619
7/9/15 16:58
7/7/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.d784.0961918D-1-25-18-17-7-10-419-7-202514
7/9/15 16:58
7/7/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS.d-56429.706-19-5218D-1-25-18-17-7-10-419-7-202514
6/9/15 17:14
6/8/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.d743.8851918D6-12-2030-2110-7-63615
6/9/15 17:14
6/8/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS.d-61832.515-19-5218D6-12-2030-2110-7-63615
5/13/15 16:01
5/11/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.d873.4662518D-26-15-16-5129030-1121-7
5/13/15 16:01
5/11/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS.d-63631.806-20-5318D-26-15-16-5129030-1121-7
4/8/15 17:11
4/7/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS.d-69734.8710-20-6113D-510-11-13-17-5-8-3-3-20-16-31-9
4/8/15 17:11
4/7/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.d193.881056613D-510-11-13-17-5-8-3-3-20-16-31-9
3/10/15 16:07
3/9/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS-80540.258-20-4228D-206311070000-14-20-29-32
2/11/15 16:02
2/9/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS-73336.659-20-3048D-172625-3-4-50-3-28-19-29-36
1/22/15 16:17
1/21/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PM.d50.400011132269D-244634-94-5-5123-13-17-12
1/9/15 17:47
1/7/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS.d-79239.6215-20-2657D0363615467-1-1-11-17-27-16
12/9/14 17:27
12/8/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS-88043.9911-20-2177D642773232911190-13-5-6-28-4
11/14/14 16:01
11/12/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS-66133.048-20-1797D81101814329-121314-26
10/9/14 16:58
10/7/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS.m-59429.716-20-15117D30-2007232-320174017-16
9/10/14 20:04
9/8/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS.m-48924.464-20-13137D-49-27-15-14-10-51-219696222
8/15/14 16:14
8/14/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS-52129.785-18-10157D-32-5-10710-1-12-1413275
7/9/14 17:54
7/7/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS-55531.7412-18-9174D-29-20-6-15-17-151-10-3-327-5
6/11/14 16:38
6/9/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS-47531.6511-15-7192D30-3006141154-7-2430-4
5/21/14 18:52
5/19/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagKnopf John LMADOCEO,PS-47331.5212-15-7207D61-28-12-8016515-31212

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact